Long-term oral carvedilol in chronic heart failure.

  title={Long-term oral carvedilol in chronic heart failure.},
  author={Andrea di Lenarda and Gastone Sabbadini and Mich{\`e}le Emilia Moretti and Gianfranco Sinagra},
  journal={Expert opinion on pharmacotherapy},
  volume={5 6},
The long-term beta-blockade strategy with carvedilol, metoprolol succinate or bisoprolol is now strongly recommended to reduce the rates of mortality and morbidity in patients with chronic heart failure (CHF). Although the benefits observed with such drugs are viewed as a class effect, theoretically, carvedilol might be superior to the other two agents… CONTINUE READING